Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | TTR | P02766 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrahydrofuran SCHEMBL6364293 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TTRTSHRMEN1KMT2A | |
| Tetrahydrofuran SCHEMBL6298732 | 1.00 | — | — | |
| Tetrahydrofuran SCHEMBL378197 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TTRTSHRMEN1KMT2A | |
| SCHEMBL30432886 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TTRTSHRMEN1KMT2A | |
| Tetrahydrofuran SCHEMBL1982618 | 1.00 | — | — | |
| Tetrahydrofuran SCHEMBL479 | 1.00 | — | — | |
| SCHEMBL30466481 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TTRTSHRMEN1KMT2A | |
| SCHEMBL9576477 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TTRTSHRMEN1KMT2A | |
| Tetrahydrofuran SCHEMBL130914 | 1.00 | — | — | |
| Tetrahydrofuran SCHEMBL5125765 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7816537-B2 | Process for the manufacture of epoxybutanol intermediates | BASILEA PHARMACEUTICA AG (CH) | 2010-10-19 | — | — | US | claimed |
| US-20090299073-A1 | Process for the Manufacture of Epoxybutanol Intermediates | MULLER MARC | 2009-12-03 | — | — | US | claimed |
| EP-1954264-A2 | PROCESS FOR THE MANUFACTURE OF EPOXYBUTANOL INTERMEDIATES | Basilea Pharmaceutica AG (CH) | 2008-08-13 | — | — | EP | claimed |
| WO-2007062542-A2 | PROCESS FOR THE MANUFACTURE OF EPOXYBUTANOL INTERMEDIATES | BASILEA PHARMACEUTICA AG (CH) | 2007-06-07 | — | — | WO | claimed |
| US-12641944-B2 | Light-emitting element and light-emitting device | SHARP KABUSHIKI KAISHA (JP) | 2026-05-26 | — | — | US | disclosed |
| US-20230090252-A1 | LIGHT-EMITTING ELEMENT AND LIGHT-EMITTING DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2023-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12641944-B2 | Light-emitting element and light-emitting device | L1CAM, EPCAM, CRY1 | ALDH1A1 100/4885TTR 3875/4885TSHR 2939/4885 |
| US-20090299073-A1 | Process for the Manufacture of Epoxybutanol Intermediates | POR, CYP4A11, CYP1A1 | ALDH1A1 259/4885TTR 1895/4885TSHR 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.